← FDA Drug Approvals (Drugs@FDA)
ROSIGLITAZONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2007-01-31
Drug application
- FDA Application #
ANDA078023
- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROSIGLITAZONE
- Generic name
- Rosiglitazone Maleate
- Active ingredients
- ROSIGLITAZONE MALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- WATSON LABS
- First approval
- 2007-01-31
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown